Bayer has completed its acquisition of Monsanto in a deal valued at over $60 billion. The merger has sparked discussions in the cryptocurrency and finance sectors about the potential impact on agricultural commodities, seed technology, and biotech investments. Investors are closely monitoring the deal's impact on Bayer's share price and its future growth prospects.